Cargando...
Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
SIMPLE SUMMARY: Selective killing of cancer cells is privileged mainstream in cancer treatment and targeted therapy represents the new tool with a potential to pursue this aim. It can also aid to overcome resistance of conventional chemo- or radio-therapy. Common mutations of cancer cells (defective...
Guardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918546/ https://ncbi.nlm.nih.gov/pubmed/33672884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040795 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|